ライフサイエンスコーパス: carcinoma cell line

1 unit of calpain 2 in the AC2M2 mouse mammary carcinoma cell line.

2 leukemia cell lines and one human colorectal carcinoma cell line.

3 nating variants from the human PC-3 prostate carcinoma cell line.

4 ptotic responses in the NRP-154 rat prostate carcinoma cell line.

5 ere tested for protein production in a human carcinoma cell line.

6 ies against the Met dependent GTL-16 gastric carcinoma cell line.

7 -A (JAM-A) in the HepG2 human hepatocellular carcinoma cell line.

8 five normal human tissues, and an embryonal carcinoma cell line.

9 sis induction in the BxPC-3 human pancreatic carcinoma cell line.

10 g binding to the Caco-2 cells, a human colon carcinoma cell line.

11 ediated by medium conditioned by a prostatic carcinoma cell line.

12 entify BMP target genes in a mouse embryonic carcinoma cell line.

13 ma cell line, and KB, a human nasopharyngeal carcinoma cell line.

14 cytotoxicity against Colo-205, a human colon carcinoma cell line.

15 terally by the CT26 wild type (CT26WT) colon carcinoma cell line.

16 multiple nude mice xenografted with the A431 carcinoma cell line.

17 channel (KATP) in HepG2C3A, a hepatocellular carcinoma cell line.

18 ed in vitro using the HCT116/LUC human colon carcinoma cell line.

19 in the HN5 human head and neck squamous cell carcinoma cell line.

20 autophagic phenotype in HeLa and other human carcinoma cell lines.

21 Mahlavu liver, MCF7 breast, and HCT116 colon carcinoma cell lines.

22 liferative effects on a panel hepatocellular carcinoma cell lines.

23 ed down-regulation of FOSL1 in squamous cell carcinoma cell lines.

24 ain human prostate epithelial carcinomas and carcinoma cell lines.

25 endocrine sensitive but not resistant breast carcinoma cell lines.

26 ) and fulvestrant (ICI182780; ICI) in breast carcinoma cell lines.

27 ced motility and invasiveness of other colon carcinoma cell lines.

28 ling activation in a series of human gastric carcinoma cell lines.

29 hed the clonogenicity of all six human colon carcinoma cell lines.

30 ndent on JMJD1A in both renal cell and colon carcinoma cell lines.

31 ted depletion of HAX-1 in oral squamous cell carcinoma cell lines.

32 u and Cal27, two head and neck squamous cell carcinoma cell lines.

33 line but selective activities against human carcinoma cell lines.

34 SPR-Cas9 technology impacted the adhesion of carcinoma cell lines.

35 1 in HaCaT cells or in several squamous cell carcinoma cell lines.

36 lphaB-crystallin in two different metastatic carcinoma cell lines.

37 against LNCaP, DU145, and PC3 human prostate carcinoma cell lines.

38 ocytes and human oropharyngeal squamous cell carcinoma cell lines.

39 odiol in the cell cycle progression of human carcinoma cell lines.

40 capacity of MDA-MB-231 and MDA-MB-435 breast carcinoma cell lines.

41 ion in both papillary and follicular thyroid carcinoma cell lines.

42 ion of HeLa cells compared to hepatocellular carcinoma cell lines.

43 ar, salivary gland, cervical, and pancreatic carcinoma cell lines.

44 ty and cell uptake data in two human ovarian carcinoma cell lines.

45 icity of meayamycin B in non-small cell lung carcinoma cell lines.

46 sses metastasis in multiple human and murine carcinoma cell lines.

47 sion and metastatic growth of hepatocellular carcinoma cell lines.

48 for viral E6 expression in infected cervical carcinoma cell lines.

49 and O-GlcNAc levels are elevated in prostate carcinoma cell lines.

50 tic melanoma, prostate carcinoma, or mammary carcinoma cell lines.

51 cell sorting analysis in a variety of human carcinoma cell lines.

52 report, we characterized the human prostate carcinoma cell line 22Rv1 in an orthotopic system and ev

53 on tumor behavior, using the murine mammary carcinoma cell line 4T1.

54 vical carcinoma cell line HeLa and the renal carcinoma cell line 786-O.

55 rapy of 2 alphavbeta3-negative squamous cell carcinoma cell lines (A-431 and FaDu) that induce alphav

56 nce in intrinsic HH dependence of urothelial carcinoma cell lines, a gene expression signature was id

57 ty assay in human fibroblasts (MRC5) and two carcinoma cell lines (A375 and HCT116), interaction with

58 rathyroid glands and in the human epidermoid carcinoma cell line A431, which mimics hyperplastic para

59 C3G inhibited proliferation of a human lung carcinoma cell line, A549.

60 adenoma and carcinomas samples, seven colon carcinoma cell lines also lacked expression of RDH5 and

61 l cells (including the C666-1 nasopharyngeal carcinoma cell line), although Na does not appear to aff

62 azole 1 in growth inhibition of HCT116 colon carcinoma cell line and in inducing increases in global

63 t in vitro uptake within the DU-145 prostate carcinoma cell line and orthotopically implanted prostat

64 yngeneic beta-galactosidase-expressing colon carcinoma cell line and subsequently immunized with AdZ.

65 ed subcutaneously with a non-small cell lung carcinoma cell line and treated with paclitaxel for a pr

66 rom a 40-gene signature and is found in both carcinoma cell lines and a variety of primary tumors, in

67 the loss of EphB6 protein in invasive breast carcinoma cell lines and absence of EphB6 transcript in

68 on-small-cell lung cancer and hepatocellular carcinoma cell lines and also hepatocellular carcinoma,

69 stigated MEK5 expression in different breast carcinoma cell lines and breast cancer tissues using tis

70 expression was elevated in half of the human carcinoma cell lines and carcinoma tissue samples tested

71 cells from early stage human lung and breast carcinoma cell lines and defined the mechanisms that sup

72 DA-7/IL-24 in inducing apoptosis in prostate carcinoma cell lines and displayed transformed cell spec

73 er small RNA segments for six human cervical carcinoma cell lines and five normal cervical samples.

74 ession were examined in human hepatocellular carcinoma cell lines and human liver tissue.

75 ion were immunoprecipitated from human colon carcinoma cell lines and identified by mass spectrometry

76 In 11 of 13 (85%) renal cell carcinoma cell lines and in 16 of 37 (43%) other cancer

77 ownstream target genes and proteins in renal carcinoma cell lines and in a mouse xenograft model of r

78 mediated autophagy in Her2-expressing breast carcinoma cell lines and in Beclin-1 signaling in these

79 is a potent inducer of invadopodia, both in carcinoma cell lines and in primary human fibroblasts.

80 llels reduced EPHB3 expression in colorectal carcinoma cell lines and poorly differentiated tumor-tis

81 epithelial and mesenchymal clones from human carcinoma cell lines and showed that the epithelial clon

82 urine liver and human HCC, breast, and colon carcinoma cell lines and specimens.

83 ated-EGFR (p-EGFR) and miR-21 levels in lung carcinoma cell lines and the suppression of miR-21 by an

84 FGFR1 expression is increased in urothelial carcinoma cell lines and tumors, which promotes prolifer

85 splice variants of FGFR1 in both urothelial carcinoma cell lines and tumors.

86 esent in several head and neck squamous cell carcinoma cell lines and was required for processing and

87 eat/beta-galactosidase cells (human cervical carcinoma cell line) and CEMx174 cells (human T cell lin

88 .e., HepG2 cells (human hepatocellular liver carcinoma cell line) and HL-7701 cells (human normal liv

89 ion of KYSE-410, an esophageal squamous cell carcinoma cell line, and fibroblasts with respect to the

90 ffects against HepG2, a human hepatocellular carcinoma cell line, and KB, a human nasopharyngeal carc

91 SCC-25 cells, a human squamous cell carcinoma cell line, and primary keratinocytes were eith

92 uman breast tumor cohorts, a panel of breast carcinoma cell lines, and hepatocellular carcinomas from

93 analysis of a human pituitary tumor, breast carcinoma cell lines, and thyroid carcinoma cell lines s

94 ed normal human urothelial cells, urothelial carcinoma cell lines, and tumor samples and showed that

95 anges mediated by VEGFR-1 in this pancreatic carcinoma cell line are highly consistent with the chang

96 ent adenovirus, Ad.mda-7, several colorectal carcinoma cell lines are resistant to its antiproliferat

97 nflammation in many primary human tumors and carcinoma cell lines as distinct from their normal tissu

98 ant form of PAX6, is expressed in pancreatic carcinoma cell lines at higher levels than the canonical

99 alization to the nucleus of human colorectal carcinoma cell lines at low cell culture densities and h

100 tion of FGFR2 kinase activity in endometrial carcinoma cell lines bearing such FGFR2 mutations inhibi

101 variety of breast cancer and hepatocellular carcinoma cell lines, but not to normal-like MCF-10a bre

102 expression in H358 human non-small cell lung carcinoma cell line by blocking CDK2 activity.

103 Utilizing prostate carcinoma cell lines (C1, C2, and C3) derived from TRAMP

104 tive effects were evaluated in human colonic carcinoma cell line Caco-2 and neonatal rat models.

105 n cancer cell line A2780, the human squamous carcinoma cell line Cal27, and their cisplatin resistant

106 melanoma cell line SK-MEL-37, and pancreatic carcinoma cell line Capan-1 by the same mechanism.

107 inhibition of SIM2-s in a RKO-derived colon carcinoma cell line causes growth inhibition, apoptosis,

108 we report the generation of a choroid plexus carcinoma cell line; Children's Cancer Hospital Egypt (C

109 We show here in both pancreatic and prostate carcinoma cell lines cobalt chloride (used to mimic hypo

110 Knockdown of EBP50 in human colorectal carcinoma cell lines compromised cell cycle progression,

111 ates a subset of p53 target genes in a colon carcinoma cell line, consistent with the observation tha

112 Nasopharyngeal carcinoma cell lines constitutively expressed C/EBPbeta

113 bicin on chromatin dynamics in squamous cell carcinoma cell lines derived from genetically defined mi

114 pVHL-defective clear cell renal cell carcinoma cell lines display unexpectedly variable sensi

115 lls have functional Sdccag1, five human lung carcinoma cell lines do not, even though Exportin still

116 r metastasis, we used two different prostate carcinoma cell lines, DU145 and PC3, in which the expres

117 In several male carcinoma cell lines, DXZ4 can adopt a Xi-like conformat

118 ecific antitumor agent against MCF-7 (breast carcinoma) cell lines (ED50 = 3.7 x 10(-3) microg/mL com

119 ) expression) or the BxPC-3 human pancreatic carcinoma cell line (endogenous alpha(v)beta(6) expressi

120 d human urothelial cells and many urothelial carcinoma cell lines exhibit constitutive HH signaling,

121 We find that ovarian carcinoma cell lines exhibit greater sensitivity to apop

122 However, four of five pancreatic carcinoma cell lines exhibited either elevated Mirk acti

123 ntrast, tumors arising from more mesenchymal carcinoma cell lines exhibiting EMT markers expressed lo

124 imary human hepatocytes and 4 hepatocellular carcinoma cell lines exposed to combinations of cytokine

125 ary tumor cells arising from more epithelial carcinoma cell lines expressed high levels of MHC-I, low

126 recently demonstrated that the LS174T colon carcinoma cell line expresses the CD44 glycoform known a

127 ted cell growth of an aggressive human colon carcinoma cell line, FET6alphaS26X, which harbors consti

128 approach to knockdown CYP1B1 in endometrial carcinoma cell line followed by functional assays.

129 Thus, six of seven colon carcinoma cell lines from the NCI Anticancer Drug Screen

130 (+) pump) has been studied in the human lung carcinoma cell line H1299 that expresses YFP-tagged alph

131 ability, and cellular ATP levels of the lung carcinoma cell lines H1299 and A549.

132 A human adrenal carcinoma cell line (H295R) overexpressing human aldoste

133 onged exposure of a gefitinib-sensitive lung carcinoma cell line (H3255; EGFR mutated and amplified)

134 ed the migratory behavior of a squamous cell carcinoma cell line (HaCaT-II-4) upon E-cadherin suppres

135 We found a colorectal carcinoma cell line harboring the fusion gene to be depe

136 lNapOH- and XylNap-primed GAGs from a breast carcinoma cell line, HCC70, and a breast fibroblast cell

137 identified LSR splice variants in the colon carcinoma cell line HCT116 and disrupted the LSR gene in

138 1 conditional allele in the human colorectal carcinoma cell line HCT116 in which several exons encodi

139 ucture-dependent toxicity to the human colon carcinoma cell-line HCT116 p53(++), causing dramatic cha

140 ays controlled by p53, isogeneic human colon carcinoma cell lines (HCT116) differing only in the pres

141 tive activities against the human colorectal carcinoma cell lines HCT116N and HCT116O, an isogenic mo

142 ts between two unrelated cells, the cervical carcinoma cell line HeLa and the renal carcinoma cell li

143 e, we show that pretreatment of two cervical carcinoma cell lines, HeLa and SiHa, with curcumin befor

144 colon cancer cell line HT-29, hepatocellular carcinoma cell line HepG2, melanoma cell line SK-MEL-37,

145 nous expression levels in the hepatocellular carcinoma cell line HepG2.

146 studied using the human liver hepatocellular carcinoma cell line HepG2.

147 odels consisting of the human hepatocellular carcinoma cell line (HepG2) and primary rat hepatocytes

148 induced effects using a human hepatocellular carcinoma cell line, HepG2 cells.

149 nce, restoration of expression in a prostate carcinoma cell line homozygous for the frameshift mutati

150 3611 rendered the strain cytotoxic to a lung carcinoma cell line; however, only prtS induction was su

151 cell line, HaCaT, but did in a human gastric carcinoma cell line, HSC-39.

152 ell cytotoxicity assays with the human colon carcinoma cell line (HT-29) showed that internalized NCP

153 apoptosis and cell cycle in the human colon carcinoma cell line, HT-29.

154 of wild type APC into an APC-deficient colon carcinoma cell line (HT29) resulted in increased express

155 Adenoma (PC/AA/C1 and RG/C2) and carcinoma cell lines (HT29) were growth stimulated by PG

156 usion protein (114 kD) in the hepatocellular carcinoma cell line HUH7, as well as in liver tumors, es

157 regulation of MIR122 in human hepatocellular carcinoma cell lines (Huh7 and HepG2) as well as in C57B

158 modifications in five ovarian epithelial and carcinoma cell lines (human 'immortalized' ovarian surfa

159 n leukemia cells and human colon and gastric carcinoma cell lines (IC(50) values as low as 1 muM).

160 a study of gene expression in the RKO colon carcinoma cell line in response to varying dosage levels

161 growth of human head and neck squamous cell carcinoma cell lines in 3D cell culture and in xenograft

162 various mouse tumor models employing murine carcinoma cell lines in immunocompetent mice.

163 cessfully characterized SCLCCs from 2 murine carcinoma cell lines in the immune-competent microenviro

164 or activity against colon, renal, and breast carcinoma cell lines in vitro (GI50 < 500 nmol/L).

165 tant and metastatic phenotype in human colon carcinoma cell lines in vitro.

166 s migration of Burkitt's lymphoma and breast carcinoma cell lines in vitro.

167 totoxic to PA-1, IGROV-1, and SK-OV3 ovarian carcinoma cell lines in vitro.

168 Overexpression of HER2 in a series of breast carcinoma cell lines increases the ALDH-expressing 'canc

169 anscript inhibited the migration of multiple carcinoma cell lines, indicating a broad role in cell mo

170 Overexpression of KLF4 in a human pancreatic carcinoma cell line induced a significant decrease in th

171 iated TRPC1 depletion in non small cell lung carcinoma cell lines induced G(0)/G(1) cell cycle arrest

172 In the human HT29Cl16E colonic carcinoma cell line, induction of goblet cell differenti

173 cells (SCLCCs) from the 4T1 and NXS2 murine carcinoma cell lines into the immune-competent microenvi

174 dogenous c-KIT expression in a human gastric carcinoma cell line is also reduced on treatment with th

175 We show that the D121 lung carcinoma cell line is E(2)-nonresponsive, and following

176 ession in choriocarcinoma, hepatoma and lung carcinoma cell lines is driven by the activity of a 66 b

177 ssed EGFRs in A431 cells, a human epidermoid carcinoma cell line, is composed of two subpopulations t

178 nsitive detection of HepG2, a hepatocellular carcinoma cell line, is described.

179 endometrial tissue and that the endometrial carcinoma cell line, Ishikawa, contains the receptors to

180 he cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resistant s

181 ostic properties against the human epidermal carcinoma cell line KB3-1.

182 , and blot rolling assays of LS174T, a colon carcinoma cell line known to interact with E-selectin un

183 of activity in the resistant A2780AD ovarian carcinoma cell line known to overexpress the ABCB1 drug

184 OXE1 and PTCSC2 in a human papillary thyroid carcinoma cell line (KTC-1) and unaffected thyroid tissu

185 In aggressive prostate and breast carcinoma cell lines, laminin-binding glycans are dramat

186 nduction of apoptosis in the human prostatic carcinoma cell line LNCaP.

187 his cyclase was investigated in the prostate carcinoma cell lines LNCaP and PC3.

188 The ovarian carcinoma cell line MA148 was genetically modified by "S

189 ignaling via the HER2/HER3 pathway in breast carcinoma cell lines may lead to enhanced NKG2D-MICA/B r

190 YAMC cells, the mouse colon carcinoma cell line MC38, the mouse macrophage cell line

191 genicity, and metastasis in Smad4-null colon carcinoma cell lines (MC38 and SW620) and in those that

192 Es), repressing transcription in the mammary carcinoma cell line MCF-7.

193 cytotoxic activity of (+)-T7 against breast carcinoma cell line MCF-7.

194 of caspase 9 gene expression in the mammary carcinoma cell line MCF-7.

195 strogen receptor-positive (ER+) human breast carcinoma cell line, MCF-7, and examined the effect of e

196 for gelatin matrix degradation in the breast carcinoma cell line MDA-MB-231.

197 Metastatic human breast carcinoma cell lines MDA-MB-231 and -435 expressing enha

198 t cell line, MCF10A, and the invasive breast carcinoma cell line, MDA-MB-231.

199 highly metastatic and invasive human breast carcinoma cell line, MDA-MB231.

200 tromal cells (MSCs) and two different breast carcinoma cell lines, MDA-MB-231 (MDA) and MA11.

201 el mouse hepatocellular SV40 large T-antigen carcinoma cell line, MHT that maintains the ability to e

202 l suspension of SCC7, a murine squamous cell carcinoma cell line; mice (n = 32) in drug delivery stud

203 we generated three isogenic human colorectal carcinoma cell line models in which we can dynamically m

204 Treatment of the human metastatic breast carcinoma cell line MT-2 with MDL28170 and 3-(4-iodophen

205 The lung carcinoma cell line NCI-H522 was found to express JAM-C.

206 nd Bcl-XL proteins and a non-small-cell lung carcinoma cell line (NCI-H460).

207 yed two EMT cell models, the human embryonic carcinoma cell line NT2/D1, and TGF-beta1-treated NMuMG

208 In the embryonal carcinoma cell line NT2/D1, ectopic DeltaN-p63-alpha dis

209 l regulator Six1 is overexpressed in ovarian carcinoma cell lines (OCC) compared with normal ovarian

210 expressed on the cell surface of peritoneal carcinoma cell lines of gastric (MKN-45P), ovarian (SKOV

211 eport MRN deficiency in three of seven colon carcinoma cell lines of the NCI Anticancer Drug Screen.

212 st breast, lung, cervical and hepatocellular carcinoma cell lines) of their methanolic extract, infus

213 n the presence of primary oral squamous cell carcinoma cell lines or coincubated with purified gangli

214 ls resulting from the culture of human colon carcinoma cell lines or primary mouse epithelial cells l

215 human melanoma cell line and a mouse mammary carcinoma cell line, our results indicate that these che

216 ancer stem cell markers in the human ovarian carcinoma cell line, OVCAR-5, and is also highly express

217 ocus in retinoic acid (RA)-treated embryonal carcinoma cell line P19, which involves receptor-interac

218 ng neuronal differentiation of the embryonic carcinoma cell line P19.

219 The exocrine human pancreas carcinoma cell line (PANC-1) and the endocrine human ins

220 ntial display analysis of the human prostate carcinoma cell line PC-3 and its highly metastatic deriv

221 wth factor (VEGF) in vitro in human prostate carcinoma cell line PC-3.

222 p72 did not reduce viability of the prostate carcinoma cell lines PC-3 and DU-145.

223 ved HSP70 release from intact human prostate carcinoma cell lines (PC-3 and LNCaP) by a mechanism ind

224 A cisplatin-resistant ovarian carcinoma cell line PE01CDDP was derived from the parent

225 rporated into cells from the human prostatic carcinoma cell line PPC-1, and shows no apparent cytotox

226 bound to the NRP-positive primary prostatic carcinoma cell line (PPC-1) but did not bind to the NRP-

227 expression is suppressed in hypermethylated carcinoma cell lines (R=-0.73).

228 tive to benign ovarian tumors and in ovarian carcinoma cell lines relative to immortalized surface ep

229 s were cocultured with the murine renal cell carcinoma cell line, Renca, a dramatic increase in apopt

230 epithelial cells, and in breast and ovarian carcinoma cell lines, represses IFN-stimulated genes (IS

231 kdown in UM-UC-3 and TCCSUP human urothelial carcinoma cell lines resulted in suppression of CD24 exp

232 Depletion of REGgamma in a thyroid carcinoma cell line results in cell-cycle and proliferat

233 RT-PCR analysis in carcinoma cell lines revealed a significant reduction in

234 Knockdown of FGFR1 in urothelial carcinoma cell lines revealed differential FGFR1 depende

235 ced apoptosis in TRAIL-resistant human colon carcinoma cell lines (RKO, HT29, and HCT8).

236 also likely to be present in a human tongue carcinoma cell line, SAS.

237 icity for the protected compounds in ovarian carcinoma cell lines sensitive and resistant to cisplati

238 ur expression in head and neck squamous cell carcinoma cell lines showed a mechanistic link between f

239 or, breast carcinoma cell lines, and thyroid carcinoma cell lines showed that in cells expressing Gal

240 We observed that the hepatocellular carcinoma cell line SKHEP1 retains productive free uptak

241 ock the migration of a highly motile ovarian carcinoma cell line, SKOV-3, by using a 384-well wound-h

242 The human renal cell carcinoma cell line SN12-C was stably transfected with p

243 We utilized the highly sensitive gastric carcinoma cell line, SNU638, and two related MET inhibit

244 A to the pathogenesis of NPC, we established carcinoma cell lines stably infected in vitro with eithe

245 t MHC class I tumor antigen of a mouse colon carcinoma cell line stimulates a tumor-specific T-cell c

246 pha-positive but not ERalpha-negative breast carcinoma cell lines, suggesting that ERbeta1 represses

247 showed in a BRG1- and BRM1-deficient adrenal carcinoma cell line, SW-13, that Tax- and 21-bp repeat-m

248 ylation profiles of the isogenic human colon carcinoma cell lines SW480 (primary tumor) and SW620 (me

249 of EGFR immune complexes from a transitional carcinoma cell line (TCCSUP) identified the phosphoinosi

250 ein expression was reduced in 6 of 16 breast carcinoma cell lines tested as compared with untransform

251 Most human ovarian carcinoma cell lines tested secreted significant levels

252 In several human carcinoma cell lines tested, HeLa (cervical), HCT116 and

253 than Ad5 WT, dl309, or dl1520 in all ovarian carcinoma cell lines tested, which was associated with e

254 on was 2.3-fold higher in G/G hepatocellular carcinoma cell lines than A/A cell lines.

255 ithelial cell line and in a low-grade serous carcinoma cell line that expressed undetectable levels o

256 beta4 in tumor progression, a SUM-159 breast carcinoma cell line that is essentially devoid of alpha6

257 BT549 is an invasive human breast carcinoma cell line that lacks expression of BAF57, a ke

258 or lactate uptake by a human cervix squamous carcinoma cell line that preferentially utilized lactate

259 ression, we generated novel isogenic colonic carcinoma cell lines that exhibit highly significant, st

260 as used to block HH signaling in human colon carcinoma cell lines that express HH signaling component

261 In two carcinoma cell lines that lack functional Brg1 and Brm,

262 We established RKO (human colorectal carcinoma) cell lines that can be induced by doxycycline

263 In a series of carcinoma cell lines, the IC50 for proliferation ranged

264 ERalpha-transfected ERalpha-negative breast carcinoma cell lines, the MDA-MB-468 and the MDA-MB-231

265 kappaB activation in five of six human colon carcinoma cell lines; this activation is inhibited by qu

266 iated ROS generation in the HT29 human colon carcinoma cell line through a Rac-dependent mechanism.

267 to a site 100 kb from a telomere in a human carcinoma cell line to address the effect of telomere pr

268 stablished model based on control of a mouse carcinoma cell line to study endogenous tumor-infiltrati

269 ferentiated and differentiated human colonic carcinoma cell lines to determine if this parasite speci

270 tes Chk1, also sensitized a variety of human carcinoma cell lines to SN-38.

271 roup, we used a preclinical model of bladder carcinoma cell lines to study a unique SV (translocation

272 nterferon (IFN)-gamma sensitizes human colon carcinoma cell lines to the cytotoxic effects of 5-fluor

273 Overexpression of IHPK2 sensitized ovarian carcinoma cell lines to the growth-suppressive and apopt

274 the responses of head and neck squamous cell carcinoma cell lines to two IFN subtypes, IFN-alpha2a an

275 ur potential selective to colon and cervical carcinoma cell lines) to be explored in the pharmaceutic

276 ed hemaglutinin-tagged GALR1 in a human oral carcinoma cell line (UM-SCC-1-GALR1) that expresses no e

277 roperties in two head and neck squamous cell carcinoma cell lines, UMSCC-10B and HN-1.

278 Three human head and neck squamous carcinoma cell lines (UMSCC1, UMSCC14A, and UMSCC22A) we

279 was measured in HCT-116, a human colorectal carcinoma cell line, using inhibitors of SHP2 and RAF.

280 ted with the 256 variants in the NCI-60 lung carcinoma cell lines, valine with high expression and is

281 e promoter methylation status of three renal carcinoma cell lines was assessed with restriction enzym

282 pression in several EBV-infected AGS gastric carcinoma cell lines was determined.

283 stitutive HH activity observed in urothelial carcinoma cell lines was HH ligand dependent.

284 inatorial mutations in the human ES2 ovarian carcinoma cell line were also assessed with TRACE.

285 Mouse serous and endometrioid ovarian carcinoma cell lines were tested in vitro against rhMIS

286 Ovarian carcinoma cell lines were transfected in vitro with dl92

287 Ovarian carcinoma cell lines were used to evaluate the effects o

288 and from low-grade to high-grade urothelial carcinoma cell lines, whereas alternatively spliced vari

289 L14 secretion by head and neck squamous cell carcinoma cell lines, whereas reintroduction of RhoBTB2

290 nt was enriched to MAF = 0.64 in NCI-60 lung carcinoma cell lines, whereas the TOP1MT R525W was enric

291 In the 4TO7 mouse carcinoma cell line, which expresses low levels of endog

292 Treatment of a human colon carcinoma cell line with alpha-DABA versus gamma-DABA ha

293 Incubation of a human embryonal carcinoma cell line with NMM reduces its stem cell trait

294 that it is applicable to 10 human colorectal carcinoma cell lines with a direct correlation between v

295 cificity of tumor cell targeting using three carcinoma cell lines with different levels of EGFR expre

296 ed miRNA characterized from isogenic bladder carcinoma cell lines with differing metastatic potential

297 tment of both APC mutant zebrafish and human carcinoma cell lines with retinoic acid significantly re

298 on of four human head and neck squamous cell carcinoma cell lines with the complete ppFur cDNA sequen

299 ementation of VHL-defective clear cell renal carcinoma cell lines with wild-type VHL restored primary

300 A2780cis (cisplatin-resistant human ovarian carcinoma) cell lines, with selected complexes' being mo